home / stock / indp / indp news

INDP News and Press, Indaptus Therapeutics Inc.

Stock Information
Company Name: Indaptus Therapeutics Inc.
Stock Symbol: INDP
Market: NASDAQ
Website: indaptusrx.com/
Menu
INDP INDP Quote INDP Short INDP News INDP Articles INDP Message Board
Get INDP Alerts

News, Short Squeeze, Breakout and More Instantly...
INDP - Indaptus Therapeutics signs $6M securities purchase agreement with David Lazar

2025-12-29 07:53:17 ET More on Indaptus Therapeutics Seeking Alpha’s Quant Rating on Indaptus Therapeutics Historical earnings data for Indaptus Therapeutics Financial information for Indaptus Therapeutics Read the full article on Seeking Alpha ...
INDP - Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announces it has entered into a ...

INDP - US Companies Moving the Markets, Morning edition
Fri, Dec 26, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Northann Corp. (NCL) rose 49.4% to $0.256 on volume of 307,511,018 shares Multi Ways Holdings Limited Class A (MWG) rose 38.1% to $0.3496 on volume of 285,283,961 shares SOBR Safe Inc. (SOBR) rose 82.3% to $2.37 on volume of 143,192,051...

INDP - US Companies Moving the Markets, Evening edition
Wed, Dec 24, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Vivakor Inc. (VIVK) fell 25.3% to $0.0348 on volume of 443,772,977 shares Northann Corp. (NCL) rose 49.4% to $0.256 on volume of 301,448,296 shares Multi Ways Holdings Limited Class A (MWG) rose 38.1% to $0.3496 on volume of 282,998,059...
INDP - Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that Michael Newman, P...

INDP - Indaptus Therapeutics GAAP EPS of -$2.98

2025-11-12 09:58:30 ET More on Indaptus Therapeutics Seeking Alpha’s Quant Rating on Indaptus Therapeutics Historical earnings data for Indaptus Therapeutics Financial information for Indaptus Therapeutics Read the full article on Seeking Alpha ...

INDP - Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announces financial results for ...
INDP - US Companies Moving the Markets, Evening edition
Fri, Sep 05, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 11.6% to $6.65 on volume of 562,729,409 shares Next Technology Holding Inc. (NXTT) rose 2.7% to $0.1468 on volume of 248,456,156 shares NVIDIA Corporation (NVDA) fell 2.7% to $167.02 on volume of 22...

INDP - US Companies Moving the Markets, Morning edition
Fri, Sep 05, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Next Technology Holding Inc. (NXTT) rose 1.5% to $0.1452 on volume of 129,832,874 shares Peraso Inc. (PRSO) rose 65.0% to $1.3499 on volume of 125,060,185 shares Opendoor Technologies Inc (OPEN) rose 11.9% to $6.6699 on volume of 98,276...

INDP - Indaptus Therapeutics Provides Clinical Update

Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with each agent NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics...
Next 10